BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Matrix Surgical USA Receives CE Mark for Its OMNIPORE®


12/20/2012 6:59:15 AM

ATLANTA, GA--(Marketwire - December 19, 2012) - Matrix Surgical USA announced today that it has received CE Mark approval as well as certification for ISO 13485:2003 for its OMNIPORE® High-density Porous Polyethylene craniofacial implants for reconstructive and aesthetic craniofacial surgery. Manufactured in the USA, OmniPore Surgical Implants meet the highest standards for quality and reliability, providing surgeons with an expanded range of options to achieve the best possible outcome for their patients.

"We can now provide surgeons in all countries recognizing the CE Mark with OmniPore Surgical Implants. These state-of-the-art sterile devices are of the highest quality and provide a cost-effective solution to the difficult challenges faced by craniofacial surgeons every day," said John O'Shaughnessy, President and CEO of Matrix Surgical USA. "We believe that our years of industry experience have contributed to reaching these important goals ahead of schedule."

"Achieving ISO certification, combined with our CE Mark, opens the door for worldwide distribution of our products," said Alvaro Rodriguez, Executive Vice President of Sales. "It demonstrates our commitment to meeting customers' requirements for the highest quality products."

Matrix Surgical USA has filed a 510(k) submission with the FDA for permission to market OmniPore Surgical Implants in the US marketplace.

The ISO 13485:2003 certification confirms that Matrix Surgical USA meets the requirements for a comprehensive Quality Management System for the design, development and manufacture of medical devices from its U.S. headquarters facility. ISO 13485 is an internationally recognized quality standard that requires an organization to demonstrate that it has the comprehensive quality management systems in place to consistently meet the specific customer and regulatory requirements applicable to medical equipment.

About Matrix Surgical USA
Matrix Surgical USA is a privately owned American company dedicated to the design, production, marketing and distribution of sterile, biocompatible craniofacial implants. Matrix Surgical USA will offer its products to health care providers in the United States and through a global network of stocking distributors in more than 60 countries around the world. Learn more at www.MatrixSurgicalUSA.com.


Contact:
Lynn Hood
Email Contact
678-974-2623

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES